Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial-Reference-Cited by-同舟云学术

Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial

Published:2019-04-03 Issue:4 Volume:14 Page:e0214727
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Naruse Mitsuhide^ORCID,Koike Yasuhiro,Kamei Nozomu,Sakamoto Ryuichi^ORCID,Yambe Yuko,Arimitsu Michinori

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014);K Shimamoto;Hypertens Res,2014

2. Pharmacological treatment and therapeutic perspectives of metabolic syndrome;S Lim;Rev Endocr Metab Disord,2014

3. The Japanese Diabetes Society: Evidence-based practice guideline for the treatment for diabetes in Japan 2013. Available from: http://www.jds.or.jp/modules/en/index.php?content_id=44.

4. Telmisartan: just an antihypertensive agent? A literature review;M Destro;Expert Opin Pharmacother,2011

5. Identification of telmisartan as a unique Angiotensin II receptor antagonist with selective PPARγ-modulating activity;SC Benson;Hypertension,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Azilsartan on clinical blood pressure reduction compared to other angiotensin receptor blockers: a systematic review and meta-analysis;Annals of Medicine & Surgery;2023-12-11

2. Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension;Frontiers in Physiology;2023-06-23

3. The Current Update on the Efficacy of Telmisartan in Patients with Hypertension: A Systematic Review;Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021);2022-12-18

4. Anti-Apoptosis of Podocytes and Pro-Apoptosis of Mesangial Cells for Telmisartan in Alleviating Diabetic Kidney Injury;Frontiers in Pharmacology;2022-04-19

5. Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus;Cureus;2022-02-16